Pharmacokinetics and Distribution of Perfluorobutylpentane, a Novel Eye Drop Vehicle, in Rabbits after Topical Administration
Overview of Clinical Efficacy and Safety of a Water-Free Cyclosporine, 0.1% Solution For Treatment of Dry Eye Disease
Corneal Staining Score Responder as a Clinically Meaningful Dry Eye Outcome
Evaluationg the Lubricationg Effect of Semifluorinated Alkanes on the Ocular Surface
The Pharmacodynamic Effect of LatanoSol Eye Drops on IOP of Normotensive Dogs
Influence of Perfluorohexyloctane Containing Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease
Ocular and Systemic Distribution of 14C-Perfluorohexyloctane Following Topical Ocular Administration to Rabbits
Semifluorinated Alkanes Enhance the Lipid Layer for Dry Eye Therapy
Exploratory Ocular Surface Distribution Studies of Azithromycin Formulations Based on Semifluorinated Alkanes
A Clincal Phase 2 Study to Assesss Safety, Efficacy, and Tolerability of CyclASol® for the Treatment of Dry Eye Disease
Semi-Fluorinated Alkanes for Topical Delivery of Cyclosporine A
Omega-3 Fatty Acids Using F6H8-Carrier as Topical Therapy in Experimental Dry Eye Disease
NovaTears® as New Therapy in Dry Eye: Results frorm Three Prospective, Multicenter, Non-Interventional Studies in Different Patient Populations
Semifluorierte Alkane als Therapie bei Meibomdrüsen-Dysfunktion: Ergebnisse einer prospektiven, multizentrischen Beobachtungsstudie
Cyclosporine A Using F4H5 as Liquid Drug Carrier is Effectie in Treating Experimental Dry Eye Disease
